US Broker Ratings

UnitedHealth Group (UNH) Stock Report: Evaluating a 27% Upside Amidst Robust Revenue Growth

UnitedHealth Group Incorporated (NYSE: UNH) stands as a titan in the healthcare sector, with a commanding market capitalization of $260.03 billion. As a diversified healthcare company headquartered in Eden Prairie,..

Royalty Pharma plc (RPRX) Growth Potential: A Deep Dive into Analyst Ratings and Valuation Metrics

Royalty Pharma plc (NASDAQ: RPRX) has carved out a unique niche in the biotechnology sector by operating as a buyer of biopharmaceutical royalties and a funder of innovation. With a..

United Therapeutics Corporation (UTHR): Analyst Consensus Reveals 22% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) is a prominent player in the healthcare sector, particularly in the specialty and generic drug manufacturing space. With a market capitalization of $20.96 billion, the..

AstraZeneca PLC (AZN) Stock Analysis: Evaluating Growth Potential with a 22.84% ROE

AstraZeneca PLC (AZN) remains a formidable player in the global healthcare sector, with its expansive portfolio of prescription medicines targeting a wide array of diseases. Based in Cambridge, UK, AstraZeneca..

Fresenius Medical Care AG (FMS) Stock Analysis: Uncovering an 18.45% Potential Upside Amidst Industry Challenges

Fresenius Medical Care AG (NYSE: FMS) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bad Homburg, Germany, the company is..

Zoetis Inc. (ZTS) Stock Analysis: A 24.35% Potential Upside in the Animal Health Sector

Investors looking for growth opportunities in the healthcare sector may want to take a closer look at Zoetis Inc. (NYSE: ZTS). As a leader in the animal health industry, Zoetis..

Cardinal Health, Inc. (CAH) Stock Analysis: A Healthcare Giant with 14.46% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable player in the healthcare sector, particularly within the medical distribution industry. With a robust market capitalization of $51.25 billion, the company..

STERIS plc (STE) Stock Analysis: 22% Potential Upside Amid Robust Revenue Growth

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, is capturing investor attention with a promising potential upside of 22.01%. With a market capitalization of $22.62 billion, STERIS..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Biotech Powerhouse with 42% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading player in the biotechnology sector, continues to captivate investor interest with its innovative approach to therapeutics. This Cambridge, Massachusetts-based company specializes in the..

Medtronic plc (MDT) Stock Analysis: Exploring a 22.87% Upside Potential

Medtronic plc (MDT) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. Headquartered in Galway, Ireland, Medtronic boasts a market capitalization of $116.71 billion,..

Danaher Corporation (DHR) Stock Analysis: Unveiling a 35.50% Upside Potential Amidst Robust Analyst Support

For those keeping a close eye on the healthcare sector, Danaher Corporation (NYSE: DHR) represents a compelling investment option. With a market capitalization of $138.25 billion, Danaher is a heavyweight..

HCA Healthcare (HCA) Stock Analysis: Evaluating Growth in a Competitive Healthcare Sector

Investors eyeing the healthcare sector for stable and potentially lucrative opportunities may find HCA Healthcare, Inc. (NYSE: HCA) a compelling case study. With a market capitalization of $119.15 billion, HCA..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Analyst Consensus Points to a 35% Upside

For investors eyeing the healthcare sector, IQVIA Holdings, Inc. (NYSE: IQV) stands out as a formidable player within the diagnostics and research industry. Based in Durham, North Carolina, IQVIA offers..

ResMed Inc. (RMD) Stock Analysis: Navigating the Healthcare Sector with a 17.64% Upside Potential

ResMed Inc. (RMD), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers intriguing prospects for investors. With a market capitalization of $36.91 billion,..

Mettler-Toledo International (MTD) Stock Analysis: Unpacking a 24% Potential Upside with Diagnostic Precision

Mettler-Toledo International Inc. (NYSE: MTD) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $24.71 billion, this Swiss-based..

Sanofi (SNY) Stock Analysis: Exploring a Potential 29.47% Upside in the Healthcare Giant

Sanofi (SNY), a leading player in the healthcare sector, is capturing investor attention with a promising potential upside of 29.47%. With a market capitalization of $107.59 billion, this Paris-based pharmaceutical..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with a 14% Upside Potential

Cencora, Inc. (NYSE: COR), a formidable player in the healthcare sector, has caught the attention of investors with its robust market presence and potential for significant upside. As a leader..

Boston Scientific Corporation (BSX) Stock Analysis: Unpacking a 46.10% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a titan in the medical devices industry, stands out with a striking potential upside of 46.10%, capturing investor attention. With its market cap soaring at..

Stryker Corporation (SYK) Stock Analysis: Exploring a 16.55% Potential Upside in the Medical Device Sector

Stryker Corporation (SYK), a prominent player in the healthcare sector, primarily focuses on medical devices. With a market capitalization of $139.51 billion, Stryker stands as a formidable force in the..

Eli Lilly and Company (LLY) Stock Analysis: Unveiling a 22.62% Potential Upside

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture the attention of investors with its promising growth prospects and significant market presence. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds